1,006 research outputs found
Angioplasty in chronic coronary syndromes after the ISCHEMIA trial: What's new? - The interventional cardiologist's point of view
No full textFocus on relevant aspects of 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
No full text
Pathophysiology of aortic stenosis and approach to treatment with percutaneous valve implantation
No full textAortic stenosis (AS) is the most commonly acquired valvular heart disease in the Western world (2-7% of the population aged >65 years) and the mortality for untreated symptomatic severe AS is up to 50-60% at 2 years in high-risk patients. This review summarizes laboratory and recent clinical investigations concerning AS and current best treatment. Particular emphasis will be placed on pathophysiology and on the concept of afterload mismatch and preload reserve in which left ventricular function is proportionately matched to level of left ventricular pressure, mainly because such studies carry important implications for both treatment with transcatheter aortic valve implantation (TAVI) and prognosis. Surgical aortic valve replacement is currently the gold-standard treatment for patients with severe symptomatic AS. Without surgery, the prognosis is extremely poor, with a 3-year survival rate 75 years with severe AS are declined for surgery. TAVI was recently introduced as a new therapeutic option for patients with AS, so the current indications, the technical differences between 2 different transcatheter aortic valves and the clinical available data will be also examined in detail
Algorithm for diagnosis of infective endocarditis after transcatheter aortic valve replacement
No full textReduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal
No full text
Novel Material and Processing Conditions for Coating Stents: Adhesion, Roughness and Tickness Evaluation
No full text
- …
